» Articles » PMID: 25323961

The Natural History of Dementia

Overview
Specialties Geriatrics
Psychology
Date 2014 Oct 18
PMID 25323961
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

This review summarizes studies on the natural history of dementia with a focus on Alzheimer's disease and vascular dementia. Understanding the course of dementia is important not only for patients, caregivers, and health professionals, but also for health policy-makers, who have to plan for national resources needed in the management of an increasing number of dementia cases. From the available published data, the life expectancy of elderly people with dementia is shorter than that of non-demented elderly. Reports on survival after a diagnosis of dementia vary from 3 to 12 years. The wide variation is partly due to the diagnostic criteria used in the studies and the sites where they were conducted (i.e. hospitals, clinics, or homes). There is an apparent difference in survival between Alzheimer's disease patients with onset of illness before 75 years and those after 75 years: the younger patients have a longer life expectancy. However, there are conflicting data on survival (in years) comparing male and female patients and comparing patients of different ethnicities. For vascular dementia, published papers on life expectancy vary between 3 to 5 years. Vascular dementia appears to have a poorer prognosis than Alzheimer's disease. The stages of severity of dementia were compared in a follow-up of a sample of Alzheimer's disease patients in Singapore, and the mean duration of the mild phase (clinical dementia rating 1) was 5.6 years, the moderate phase (clinical dementia rating 2) was 3.5 years, and the severe phase (clinical dementia rating 3) was 3.2 years. At the various phases of the disease, the demand on health-care services and economic cost are different.

Citing Articles

Adult day programs and their effects on individuals with dementia and their caregivers (ADAPT-DemCare): a realist synthesis to develop program theories on the how and why.

Nguyen H, Rahman A, Ubell A, Goodarzi Z, Maxwell C, Allana S Syst Rev. 2024; 13(1):265.

PMID: 39443968 PMC: 11515670. DOI: 10.1186/s13643-024-02683-1.


Vascular cognitive impairment: Advances in clinical research and management.

You T, Wang Y, Chen S, Dong Q, Yu J, Cui M Chin Med J (Engl). 2024; 137(23):2793-2807.

PMID: 39048312 PMC: 11649275. DOI: 10.1097/CM9.0000000000003220.


Counting what counts: assessing quality of life and its social determinants among nursing home residents with dementia.

Hoben M, Dymchuk E, Doupe M, Keefe J, Aubrecht K, Kelly C BMC Geriatr. 2024; 24(1):177.

PMID: 38383339 PMC: 10880372. DOI: 10.1186/s12877-024-04710-1.


Clinical profile and survival analysis of Alzheimer's disease patients in a Brazilian cohort.

de Melo Queiroz E, Couto C, da Cruz Mecone C, Souza Lima Macedo W, Caramelli P Neurol Sci. 2023; 45(1):129-137.

PMID: 37540343 DOI: 10.1007/s10072-023-06937-z.


Effect of mortality in cost-effectiveness modeling of disease-modifying treatment for Alzheimer's disease.

Aye S, Jonsson L, Gustavsson A, Tate A, Ptacek S, Eriksdotter M Alzheimers Dement (Amst). 2023; 15(1):e12422.

PMID: 37009338 PMC: 10053186. DOI: 10.1002/dad2.12422.